ToxSci Advance Access originally published online on September 6, 2006
Toxicological Sciences 2006 94(2):440; doi:10.1093/toxsci/kfl097
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
TO THE EDITOR
1 Community and Environmental Medicine, Faculty Research Facility, Room 100, North Campus University of California, Irvine, California 92697-1825 2 Community and Environmental Medicine, School of Medicine, University of California, Irvine, California 92697-1825 3 Department of Medicine, Division of Immunology and Allergy, University of California, Los Angeles, California 90095
E-mail: rfphalen@uci.edu.
Received August 28, 2006; accepted August 31, 2006
| The first 10% of the full text of this article appears below. |
The comments of Drs Oberdörster and Finkelstein on our recent paper (Phalen et al., 2006
) are a welcome addition to the discussion on in vitro